ngiotensin-converting enzyme inhibitor (ACEI) has a powerful suppressive effect on neointimal formation after balloon injury in the rat carotid injury model, 1 but the mechanism(s) of this effect has not been fully elucidated. On the other hand, clinical trials with ACEI for reducing restenosis after coronary angioplasty had no effect. 2 Nevertheless, the mechanism of ACEIrelated vascular proliferation is worthy of extensive investigation, not only for the management of restenosis following coronary angioplasty, but also for protection against vascular remodeling found in various disease states. ACEI not only reduces the production of angiotensin (Ang) II, but also increases bradykinin by inhibiting its degradation. 3 Bradykinin increases nitric oxide (NO) production, 4 and Farhy et al reported that the suppressive effect of ACEI on neointimal formation is partly through kinin-mediated NO production, because the effect was partially blocked by Hoe140 (kinin receptor antagonist) or N -nitro-L-arginine methyl ester. 5 They also speculated that enhanced NO production might be partly mediated by increased inducible NO synthase (iNOS) in the neointima, although there is no evidence of a role of ACEI in this enzyme. It was recently Circulation Journal Vol.66, October 2002 reported that NO induces apoptosis of vascular smooth muscle cells (VSMC) in vitro 6, 7 and that endogenous NO derived from iNOS induces apoptosis in those cells. 8, 9 Apoptosis of VSMC in the neointima after balloon injury might be the key to controlling neointimal mass. 10 However, it is still unclear how increased NO production following the administration of L-arginine, the NO precursor, or ACEI induces apoptosis after balloon injury, and whether losartan, an angiotensin AT1 receptor blocker, also induces apoptosis in the neointima, although it has been reported that losartan induces apoptosis in aortic VSMC of spontaneously hypertensive rats. 11 The purposes of this study were to investigate whether the inhibitory effect of an ACEI (enalapril) on neointimal formation after balloon carotid arterial injury in rats is mediated by increased apoptosis in the neointima and characterized by upregulated iNOS, and to observe whether or not the antiproliferative effects of an AT1 receptor blocker (losartan) on neointimal formation, even if found to be similar to those of ACEI, are related to upregulated iNOS or increased apoptosis. Because ACEI blocks not only angiotensin II production, but also increases bradykinin concentrations, leading to NO production and the possible attenuation of vascular remodeling, we also investigated the effects of increased NO production alone on vascular remodeling by using the NO precursor L-arginine. The effects of these different interventions on apoptosis were investigated under similar inhibitions against neointimal formation following arterial injury. 
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Methods

Animals and Surgical Procedures
Twelve-week-old male Sprague-Dawley rats weighing 350-400 g fed with normal chow were used (n=112). After anesthesia with sodium pentobarbital (50 mg/kg ip), a polyethylene cannula (PE-60, Becton Dickinson Co, Ltd, USA) was inserted into the right jugular vein and fixed for continuous intravenous drug administration. The cannula was connected to an osmotic infusion pump (Alzet pump 2ML2, Alzet Corp, Alzada, MT, USA) containing 2 ml of the solutions described later, and implanted subcutaneously. Next, arterial endothelial injury was inflicted in the left common carotid artery by gently advancing and withdrawing a 2F Fogarty balloon embolectomy catheter (Baxter Healthcare, Santa Ana, CA, USA) inflated with 0.1 ml of saline, which had been introduced through the external carotid artery, 3 times.
The present study was carried out under the supervision of the Animal Research Committee in accordance with the Guidelines on Animal Experiments at Fukushima Medical University School of Medicine (Approval No. 980010) and Japanese Government Animal Protection and Management Law (No. 105).
Experimental Protocol
Rats were divided into 5 treatment groups. The first group underwent saline infusion (n=9, control group). The second group was treated with L-arginine (Sigma Chemical Co, St Louis, USA) diluted with saline (30 mg/kg per day) and administered by osmotic pump from just before to 14 days after the carotid injury to investigate the effect of NO on the neointima (n=9, L-arginine group). Rats tolerated this dose of L-arginine well. In a preliminary study 3 groups of rats were infused with L-arginine at 3 mg/kg per day or 30 mg/kg per day or saline by osmotic pump for 14 days, and on the 14th day the plasma free arginine concentrations were measured with an automated amino acid analyzer (JLC-300, Nippon Denshi Corp, Japan). The arginine concentration of the group treated with 3 mg/kg per day (n=5, 115±11 nmol/ml) did not significantly increase compared with the saline group (n=6, 92.8±10.0 nmol/ml), whereas in the 30 mg/kg per day group, the plasma concentration increased 1.6 fold (n=8, 145.9±7.6 nmol/ml, p<0.01 vs control). The antiproliferative effect on neointimal growth was similar to that of enalapril, as described later. Therefore, we decided to use an infusion of 30 mg/kg per day of L-arginine in the present study. In the third group, 8 mg/kg per day of enalapril (Merck & Co, Inc, NJ, USA) mixed with drinking water was orally administered from 6 days before to 14 days after balloon injury to test the effect of ACEI on neointimal formation (n=7, enalapril group). In the fourth group, both oral enalapril and intravenous Larginine were given by the methods described to investigate the combined effects of these agents on neointimal formation (n=7, enalapril + L-arginine group). In the fifth group, 12 mg/kg per day of losartan (Merck & Co) was given orally to investigate the effect of AT1 receptor inhibition on neointimal growth without affecting the kinin system (n=8, losartan group). A preliminary study using this dose (n=5) showed that the antiproliferative effect on neointimal growth was similar to that in the enalapril group. The doses of enalapril and losartan used in this study were principally based on previous reports, 1, 5, 12 and this will be discussed further.
Blood Pressure Measurement
Systolic blood pressure (SBP) was measured by the tail cuff volume-oscillometric method (UR-5000, UEDA Ltd, Japan) in conscious animals just before and 14 days after the balloon injury. We also measured SBP just before enalapril or losartan treatment. The number of rats in which SBP was measured was 7 (control group), 9 (L-arginine group), 7 (enalapril group), 7 (enalapril + L-arginine group), and 8 (losartan group).
Morphology/Morphometry of the Balloon-Injured Artery
Fourteen days after balloon injury, the chest was opened under anesthesia, and a catheter for saline infusion or perfusion-fixation was placed in the ascending aorta via the left ventricle. The right atrium was cut for blood drainage and the vascular system was rapidly rinsed with approximately 100 ml of phosphate-buffered saline (PBS) infused from the ascending aorta and perfusion-fixation was performed with 4% buffered paraformaldehyde at a perfusion pressure of 100 mmHg. The left common carotid artery was then cut, removed, and immersed in 4% buffered paraformaldehyde for further fixation for 1 h. After rinsing in PBS for 2 h, the strip was embedded in paraffin. A 2-m thick cross-sectional ring was made. Four cross-sections of each artery spaced at 0.4-mm intervals were stained with elastic Van Gieson stain for histomorphometric measurements by light microscopy. The intimal or medial area of the cross-section was measured by a computer-based morphometric analyzing system (NIH image Version 1.59./ppc, USA) and the ratio of the neointimal area to that of the media was calculated. Data from 2 rats (ie, one each in the enalapril + L-arginine group and the losartan group) were omitted because perfusion-fixation could not be performed completely. The number of intimal area/medial area ratios analyzed was 9 (control group), 9 (L-arginine group), 7 (enalapril group), 6 (enalapril + Larginine group), and 7 (losartan group).
Immunohistochemical Analysis for iNOS Expression in the Injured Artery
Five groups (control, L-arginine, enalapril, enalapril + Larginine and losartan; n=6 each) underwent the same experimental protocol as described. Two weeks after the injury, the left common carotid artery was removed and fixed in 4% buffered paraformaldehyde. To investigate the expression of iNOS in the neointima after balloon arterial injury, we performed immunostaining for iNOS using a previously described method 13 with minor modifications. Briefly, the cryostat sections were incubated at 4°C with PBS containing primary antibody (iNOS antibody, which is rabbit polyclonal antibody to murine macrophage iNOS; Affinity BioReagents, USA; 1A4 antibody, which is murine polyclonal antibody to the single isoform of -smooth muscle actin; DAKO, Japan). After washing with PBS, the slides were incubated with biotin-conjugated secondary antibody (swine anti-rabbit immunoglobulins for iNOS antibody; rabbit anti-mouse immunoglobulins for 1A4 antibody, DAKO, Japan) for 30 min at room temperature. The avidin-biotin immunoperoxidase complex (Strept ABC Complex.HRP; DAKO, Japan) diluted in 0.05 mol/L TRIS buffer was then applied for 30 min at room temperature. Slides were then incubated with 1.4 mol/L 3,3'-diaminobenzidine in PBS (Wako Pure Chemical Ltd, Japan). The sections were then counterstained with hematoxylin and photographed using a microscope (Olympus VANOX-S, Japan) for quantification of immunostaining for iNOS.
Quantification of Immunostaining for iNOS.
To quantify iNOS in the neointima, the relative intensity of positive immunostaining was measured by an image analysis method 14 using a computer-based morphometric analyzing system, as described previously. Intensity of staining was assessed by the degree of light absorption in the sample using a gray scale (0-255), representing the fraction of incident light transmitted through the sample. Optical density (OD) was calculated by the following equation:
The data are presented as average OD in positive staining areas. To eliminate technical inconsistencies, all samples to be quantified were prepared and stained at the same time.
Western Blot Analysis
Western blotting 15 was performed to compare the iNOS expression in the neointima between the control (n=3) and enalapril groups (n=3). The left carotid artery with the neointimal lesion of each rat was removed and lysed with hypotonic buffer. Aliquotes containing 20 mg of protein were subjected to sodium dodecyl sulface/polyacrylamide gel electrophoresis (10% running gel, 5% stacking gel, PAGEL, ATTO Co) and then transferred onto polyvinylidine difluoride membranes (MILLIPORE). After incubating with blocking solutions at room temperature for 30 min, the membranes were incubated for 60 min at room temperature with mouse monoclonal antibody to iNOS diluted 1:500 (Affinity BioReagents, USA) and then for 45 min with a horseradish peroxidase-conjugated goat anti-mouse IgG diluted 1:10000 (Santa Cruze). The signals from immunoreactive bands were visualized by an Amersham ECLSystem (Amersham Pharmacia Biotech UK Lit).
In Situ Detection of Apoptotic Cells
We identified apoptotic cells with DNA breaks in the nucleus in situ in tissue sections by the terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labeling (TUNEL) method as described by Gavrieli et al. 16 The cells with clear nuclear labeling were defined as TUNEL positive and the TUNEL positive rate was defined as the percentage of TUNEL positive cells in 200 cells of neointima in random fields under high magnification. In this study each cross-section was obtained from the same strip used for morphometry analysis, and the number in each group was the same as for morphometry analysis.
TUNEL and PCNA on SMC in the Neointima 7 Days After the Balloon Injury
To see the differences in apoptosis and proliferative activity of SMC in the neointima after the carotid injury in the control, enalapril and losartan groups, 3 rats from each group underwent perfusion -fixation, as described earlier, at 7 days after the injury. Harvested strips underwent TUNEL staining as before. Moreover, immunostaining for mouse anti-proliferating cell nuclear antigen (PCNA; Dako, Japan) was done overnight at 4°C. Subsequently, sections were incubated with peroxidase conjugated secondary antibodies (rabbit anti-mouse immunoglobulins 1:400, Dako, Japan) for 30 min at room temperature. Strept ABC Complex diluted in TRIS buffer was then applied for 30 min at room temperature and the slides were then incubated with 1.4 mol/L 3,3'-diaminobenzidine in PBS. The sections were then counterstained with hematoxylin. The TUNEL-positive and PCNA-positive rates in 200 neointimal cells were compared among the 3 groups.
Transmission Electron Microscopy
Another 3 rats in the control group were perfusion-fixed at 100 mmHg in 2.5% glutaraldehyde (pH7.3) buffered with 0.1 mol/L sodium cacodylate, and the denuded portion of the carotid artery was harvested and fixed in 2.5% buffered glutaraldehyde overnight at 4°C, then washed with 0.1 mol/L sodium cacodylate buffer for 15 min before postfixation with 1% osmium tetroxide buffered with 0.1 mol/L sodium cacodylate for 1 h at 4°C. After another wash with 0.1 mol/L sodium cacodylate for 15 min, tissues were dehydrated in an alcohol series (30%, 50%, 70%, 80%, 95%, once for 10 min at each concentration and twice for 30 min at 100%). The tissue was infiltrated with propylene oxide twice for 5 min, followed by 1:1 = propylene oxide: epon overnight and embedded with 100% epon for 2 h and placed in a 60°C oven for 24 h. Semi-thin sections were stained with toluidine blue, and ultrathin sections of the areas of interest were stained with uranyl acetate and lead citrate. The tissue was examined with an electron microscope (model JEM-100SX, Jeol Ltd, Tokyo, Japan).
Statistical Analysis
Data are expressed as mean±SEM. Comparisons of SBP between pre-and post-oral drug administration, or between pre-and post-intervention were analyzed using a Student's t-test. Comparisons among more than 2 groups were performed by one-way analysis of variance, and Bonferroni /Dunn's test as a post hoc test. Values were considered statistically significant at p<0.05. (Table 1) L-arginine, enalapril and losartan all decreased SBP with no significant differences in the pressure reduction between the 3 drugs. Losartan further decreased SBP 2 weeks after the carotid injury, but not enalapril nor the combination of enalapril and L-arginine.
Results
Changes in SBP
Effects of Balloon Arterial Injury on Carotid Neointima
In the control group, marked neointimal formation in the injured carotid artery was observed (Fig 1. A1) , and the mean values of intimal area, medial area, and the intimal area/medial area ratio were 0.158±0.014 mm 2 , 0.137± 0.012 mm 2 and 1.176±0.061 mm 2 , respectively. No differences in medial area were found between the 6 treatment groups. L-arginine (45±7%), losartan (40±6%) and enalapril (35±4%) reduced the intimal area/medial area ratio. Fig 1 B1 is an example of treatment with enalapril. The reduction in the intimal area/medial area ratio in the enalapril + L-arginine group was significantly higher (65±8%) than in the enalapril, L-arginine or losartan groups (p<0.05, each) (Fig 2) . There were no differences in the intimal area/medial area ratios between the losartan, L-arginine and enalapril groups.
Effects of the Treatments on iNOS Expression
Almost all cells in the neointima and media in all 5 treatment groups were positive with 1A4 antibody immunostaining, indicating that SMC are predominant (Fig 1 A2,  B2 ). Positive immunostaining for iNOS was observed in the neointimal cells in all samples from the 5 groups and iNOS was consistently present in the luminal side of the neointima (Fig 1 A3, B3 ). There were no differences in the intensity of staining for iNOS between the control, L-arginine and losartan groups (Fig 3) . In contrast, the intensity of staining in the enalapril and enalapril + L-arginine groups was approximately 1.9-fold that of the control group.
Western blotting revealed that enalapril increased the levels of iNOS in the neointima (Fig 4) .
TUNEL Staining
Apoptotic cells in the control group were detected by TUNEL in the neointima just beneath the lumen (Fig 1 A4) . Fig 2. Comparisons between the 5 groups of the ratio of intimal to medial cross-sectional areas 2 weeks after balloon injury. Bars indicate standard errors. *p<0.001 vs control group; † p<0.05 vs L-arginine group, enalapril group and losartan group. The intimal area/medial area ratios of the drug treatment groups were significantly less than that of the control group, and that of the enalapril + L-arginine group was significantly less than those of the L-arginine, enalapril and losartan groups. In contrast, in the treated groups, especially the enalapril group, there were more TUNEL-positive cells deeper into the neointima (Fig 1 B4) . TUNEL positivity was higher in the L-arginine group (18.1±1.7%) than in the control group (9.2±1.0%, p<0.001), and higher in the enalapril group (26.2±1.1%) than in the L-arginine group (p<0.01) (Fig 5) . It was highest in the enalapril + L-arginine group (37.1± 3.3%). The losartan group (14.9±1.1%) was higher than the control group (p<0.001), but lower than the enalapril and enalapril + L-arginine groups (p<0.001).
TUNEL and PCNA at 7 Days After Injury (Table 2)
The TUNEL positive rate increased in the groups in the following order: control group, losartan group and enalapril group. The PCNA positive rate was decreased in the control group, then the enalapril group and finally the losartan group.
Transmission Electron Microscopy
Transmission electron photomicrographs showed apoptotic changes (ie, cytoplasmic shrinkage and characteristic nuclear chromatin condensation) of SMC in the neointima of the left carotid artery of the control group 2 weeks after balloon injury (Fig 6) .
Discussion
Imanishi et al demonstrated that human endothelial cells overlying atheromatous plaque express FasL and induce VSMC apoptosis via the Fas -FasL pathway in the atherosclerotic lesion. 17 We have shown the involvement of apoptosis in the inhibitory effect of ACEI on neointimal formation after balloon arterial injury and, moreover, that there are 3 apoptotic actions relevant to ACEI; that is, a NO-related action, blocking the AT1 receptor and then increased NO with iNOS upregulation.
NO induces apoptosis in VSMC in vitro, 6,7 but there has not been a report of NO or L-arginine inducing apoptosis in VSMC in the neointima of an in vivo balloon injury model. Holm et al reported anti-apoptotic effects of oral L-arginine administration on VSMC in the neointima in a balloon injury model in which a reduction of TUNEL positive cells compared with the control (without the treatment) was found in the decreased neointimal area 14 days after injury. 18 They considered that the decreased neointimal area was probably caused not by NO-induced apoptosis, but by inhibition of VSMC proliferative activity because PCNA positive cells in the L-arginine treatment group were decreased 14 days after injury. However, in the present study, increased TUNEL-positive cells were observed in the neointima 14 days after injury by intravenous infusion of L-arginine, in principle in accordance with the results obtained from the in vitro studies. 6, 7 The reason why we achieved different results is unclear. One possible explanation is the different methods of administering L-arginine (ie, intravenous vs oral) and subsequently different concentrations of NO; however, NO concentration in the neoin- .01 vs L-arginine group; ‡ p< 0.001 vs enalapril group; § p<0.001 vs losartan group. TUNEL positivity was higher in the L-arginine group compared with the control group, was further increased in the enalapril group compared with the L-arginine group, and was highest in the enalapril + L-arginine group. The losartan group was higher than the control group, but was less than the enalapril and enalapril + L-arginine groups. tima was not measured in either study. The binding receptors of angiotensin II are the AT1 and AT2 receptors. Activation via the AT1 receptor induces an anti-apoptotic signal whereas that of the AT2 receptor leads to an apoptotic signal in VSMC in vitro. 17 However, there has not been an in vivo study showing how activation via the AT1 or AT2 receptor affects apoptosis of VSMC in the neointima after arterial injury. We have demonstrated that losartan (an AT1 receptor blocker) significantly increases apoptosis in the neointima compared with a control, confirming previous in vitro data. 19 The effects were comparable with those of L-arginine, but were smaller than with enalapril.
Group
Recently, Holm et al reported that captopril increased apoptosis of VSMC in the media 2 days after carotid arterial injury in the rat, and decreased the cellularity of the neointima 14 days after the injury. 20 However, there were no differences in VSMC apoptosis in the neointima between captopril treatment and the control 14 days after injury. In contrast, our results demonstrated that enalapril increases apoptotic cells in the neointima 14 days after injury. Although we cannot explain why our results differ from theirs, it is probable that the effect of ACEI on the induction of apoptosis is not the same for each ACEI. Moreover, there were significantly more TUNEL-positive cells in the neointima of enalapril treated animals than in animals treated with L-arginine or losartan (Fig 5) , despite a similar reduction in the intimal area/medial area ratios (Fig 2) . A possible explanation for this might be that enalapril blocks the AT1 receptor mediated anti-apoptotic signal and also inhibits the degradation of bradykinin, which induces NO release from adjacent intact endothelial cells, 3, 5 and the subsequent increase in NO caused by the accumulated bradykinin might promote apoptosis in the enalapril treated animals, as reported in an in vitro study. 7 Furthermore, we demonstrated that enalapril increased iNOS concentration in the neointima (Fig 3) suggesting that iNOS-induced NO might contribute to the increased apoptosis in the neointima in the enalapril group.
It is of interest that in the present study the expression of iNOS in the neointima increased in the enalapril treatment group at 2 weeks after arterial injury, compared with the other groups, and this is the first time such a finding in in vivo conditions has been reported. One possibility for the increased iNOS is that inhibition of kinin degradation by the ACEI may exert complex and multiple actions on a number of systems, such as interleukins in the vascular SMC, 5, 21, 22 which may induce iNOS in the neointimal SMC. 23 Thus, it seems likely that the enalapril + L-arginine group had increased TUNEL-positive cells in the neointima and more reduced neointima formation compared with the enalapril alone group because of the antiproliferative action of NO-induced apoptosis via upregulated iNOS. However, it should be noted that the present results concerning upregulation of iNOS were obtained with enalapril and further experiment is necessary to assess how this iNOS expression presents with other ACEI.
We observed that intimal area/medial area ratios at 14 days after arterial injury were comparable between enalapril and losartan although TUNEL positivity in the enalapril group was greater (Table 2 ). However, with PCNA assay the anti-proliferative effect of losartan was greater than that of enalapril, despite the apoptotic action of losartan being lower than enalapril at 7 days. These results might reflect no significant difference in neointimal formation between the enalapril and losartan groups at 14 days after arterial injury.
Study Limitations
First, we did not test the dose-dependent effects of each drug, and therefore it is difficult to make direct comparisons between individual drugs. Instead, our intention was to demonstrate how the inhibition of angiotensin II dependent proliferation, the inhibitory action of degradation of bradykinin following ACEI administration, or the direct action of increased NO production itself works on apoptosis of VSMC in the neointima under the conditions of similar effects against neointimal formation in the remodeling process following arterial injury. Second, although we demonstrated apoptotic cells in the neointima by transmission electron photomicrographs, the positive labeling for TUNEL indicates not only the presence of double-stranded DNA breaks but also that of single-stranded DNA breaks with 3'-OH terminals. 16 Thus, TUNEL positive cells are observed in necrotic cells as well as apoptotic cells. 24, 25 Moreover, TUNEL-positive cells can be seen among living cells at the stage of active gene transcription. 26, 27 Therefore, the TUNEL-positive cells in our results do not necessarily represent only apoptosis. However, there is no other way than TUNEL to semiquantitatively assess apoptosis in vascular tissue. Third, we chose only 1 time point after arterial injury because we considered that maximal proliferation and apoptosis in the SMC in the neointima would be observed within the first 2 weeks. 10, 28, 29 Therefore, a possible distortion in the time course of the effects must be taken into account. Fourth, deBlois et al reported that 1-, 2-and 4-week treatments of losartan or enalapril stimulated apoptosis of VSMC in the media of the aorta in spontaneously hypertensive rats, 30 and that losartan induced greater apoptotic activity of the VSMC of the aorta at 2 weeks after treatment than enalapril. In contrast, we found that enalapril showed greater apoptotic activity at 1 and 2 weeks after injury (ie, after about 2 and 3 weeks of treatment) than did the losartan group. However, they used a pressure-overload model whereas we used a ballooninjured model. Moreover, they investigated the apoptosis in aortic medial VSMC whereas we investigated neointimal VSMC of the carotid artery. These differences in study protocol may contribute to the different results.
Conclusion
Our results suggest that apoptosis induced by enhanced NO production with upregulated iNOS, as observed in the enalapril treatment group, plays an important role in reducing neointimal mass, and that the upregulation of iNOS by enalapril might be induced via the kinin system. The present study also showed that in the in vivo rat carotid injury model not only apoptosis but also other inhibitory mechanisms against VSMC proliferation activity via increased NO or via the blockade of the AT1 receptor pathway may be important for inhibition of neointimal formation. Thus, further study is recommended regarding the justification of combination therapy using ACEI, AT1 blocker and L-arginine for protection against the vascular remodeling that follows arterial injury. 
